Save the Date!

Earn Up to 2 hours of CME!

Date: March 27, 2025

Zoom Platform

Pre-Registration is required.

Registration Fee: $25.00

This virtual continuing medical education program is designed to provide healthcare professionals with a comprehensive understanding of the latest advancements in the diagnosis, management, and treatment of Alzheimer's disease (AD). The program will delve into the evolving role of neuroinflammation in the progression from mild cognitive impairment (MCI) to AD/dementia, offering new perspectives on disease pathology. By comparing the efficacy, safety, and administration protocols of approved and investigational ATTs, attendees will gain practical knowledge on selecting appropriate therapeutic approaches tailored to individual patient needs